MetLife, Inc. MET-PA
18.97 USD -0.27 (-1.40%)
As ofNov 17, 2026, 2:53 PM EST
18.92 Day range 19.50
18.92 52-week range 22.80
- YTD
- -12.26%
- 1 year
- -16.73%
Included in Essentials and up
Sign in to see P/E against peers
The price to earnings ratio beside the closest competitors and their median.
Included in Essentials and up
Sign in to see Cash flow and returns
How profit turns into free cash flow, and the returns on equity, assets and capital.
Financial health
Altman Z-Score
0.79 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
8 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
A-4 / 5 overall
- DCF 5
- Return on Equity 5
- Return on Assets 2
- Debt / Equity 3
- P/E 4
- P/B 1
Valuation
P/E 16.4×
P/S 0.7×
P/B 1.8×
P/FCF 2.9×
EV/EBITDA 7.8×
EV/Sales 0.7×
FCF Yield 34.5%
Profitability
Gross Margin 36.4%
Operating Margin 6.0%
Net Margin 4.4%
ROE 11.9%
ROIC 0.7%
ROA 0.5%
Growth (YoY)
Revenue 10.2%
Operating Income -17.1%
EPS (diluted) -19.2%
Free Cash Flow 19.8%
Financial Health
Current Ratio 0.7×
Quick Ratio 0.7×
Debt / Equity 0.7×
Net Debt / EBITDA -0.3×
Interest Coverage 4.4×
Dividends
Dividend Yield 3.2%
Payout Ratio 50.4%
Annual · latest fiscal year ends 2025-12-31
